Valuation: PolyPeptide Group AG

Market Cap 1.46B 1.64B 1.34B 1.22B 2.3B 155B 2.36B 16.06B 6.42B 82.11B 6.16B 6.03B 259B P/E 2026 *
54.5x
P/E 2027 * 28.9x
Enterprise Value 1.56B 1.75B 1.43B 1.3B 2.45B 166B 2.52B 17.17B 6.87B 87.78B 6.58B 6.44B 277B EV / Sales 2026 *
3.11x
EV / Sales 2027 * 2.77x
Free-Float
98.54%
Yield 2026 *
-
Yield 2027 * 0.15%
1 day-0.99%
1 week-3.81%
Current month-3.81%
1 month-8.29%
3 months-8.08%
6 months+0.75%
Current year+54.79%
1 week 40.25
Extreme 40.25
43.95
1 month 40.25
Extreme 40.25
44.3
Current year 23.1
Extreme 23.1
50.1
1 year 21.8
Extreme 21.8
50.1
3 years 13.22
Extreme 13.22
50.1
5 years 13.22
Extreme 13.22
146
10 years 13.22
Extreme 13.22
147.4
Manager TitleAgeSince
Chief Executive Officer 54 12/04/2023
Director of Finance/CFO 54 02/01/2024
Chief Tech/Sci/R&D Officer 54 -
Director TitleAgeSince
Director/Board Member 73 01/01/2006
Chairman 69 01/04/2021
Director/Board Member 62 01/01/2021
Date Insider Type Main position Quantity % Market Cap. Importance
13/11/23 Buy 2,500 0.0075%
12/10/23 Buy 159,959 0.4829%
06/04/23 Buy 45,842 0.1384%
Change 5-day change 1-year change 3-year change Capi.($)
-0.99%-3.81%+72.65%+95.93% 1.64B
-3.76%-0.65%+47.41%+140.35% 1,216B
-1.45%-1.05%+46.41%+79.94% 656B
-2.24%-0.88%+32.97%+103.82% 509B
-2.16%-5.28%+44.08%+61.12% 384B
-2.27%+0.42%+74.12%+42.14% 362B
-2.17%-1.99%+28.65%+55.65% 311B
-3.40%-2.82%+5.70%+32.02% 293B
-3.80%-0.10%+43.90%+70.56% 249B
-3.96%+1.18%+36.70%+105.38% 208B
Average -2.30%-0.13%+43.26%+78.69% 418.94B
Weighted average by Cap. -2.01%+0.03%+42.46%+90.93%

Financials

2026 *2027 *
Net sales 502M 563M 459M 418M 788M 53.23B 809M 5.52B 2.21B 28.19B 2.11B 2.07B 88.95B 576M 646M 527M 480M 904M 61.09B 929M 6.33B 2.53B 32.35B 2.43B 2.37B 102B
Net income 23.5M 26.38M 21.5M 19.58M 36.91M 2.49B 37.9M 258M 103M 1.32B 99.01M 96.88M 4.17B 45.23M 50.76M 41.37M 37.68M 71.02M 4.8B 72.93M 497M 199M 2.54B 191M 186M 8.02B
Net Debt 101M 113M 92.34M 84.1M 159M 10.71B 163M 1.11B 444M 5.67B 425M 416M 17.89B 131M 147M 120M 109M 206M 13.88B 211M 1.44B 575M 7.35B 551M 540M 23.2B
Projected Income Statement - Annual - PolyPeptide Group AG
Logo PolyPeptide Group AG
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Employees
1,460
Date Price Change Volume
06/11/26 CHF 40.40 -0.25% 12,285
05/11/26 CHF 40.50 -2.06% 17,693
04/11/26 CHF 41.35 -2.93% 24,358
03/11/26 CHF 42.60 +3.02% 22,945
02/11/26 CHF 41.35 -1.55% 27,079
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - PolyPeptide Group AG
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
44.28EUR
Average target price
46.32EUR
Spread / Average Target
+4.62%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - PolyPeptide Group AG
  1. Stock Market
  2. Stocks
  3. PPGN Stock